Loading clinical trials...
Loading clinical trials...
A Multicenter, Vehicle-controlled, Double-Masked, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
Conditions
Interventions
AGN-242428
AGN-231868
+3 more
Locations
11
United States
Cornea and Cataract Consultants of Arizona /ID# 232769
Phoenix, Arizona, United States
The Eye Research Foundation /ID# 232696
Newport Beach, California, United States
Vision Institute Central /ID# 239910
Colorado Springs, Colorado, United States
The Eye Care Institute /ID# 232683
Louisville, Kentucky, United States
Andover Eye Associates /ID# 232689
Andover, Massachusetts, United States
Vita Eye Clinic /ID# 232721
Shelby, North Carolina, United States
Start Date
March 4, 2020
Primary Completion Date
March 18, 2022
Completion Date
March 18, 2022
Last Updated
May 20, 2025
NCT07463950
NCT07363824
NCT07396441
NCT07295691
NCT03135327
NCT06841471
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions